Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,035,473 papers from all fields of science
Search
Sign In
Create Free Account
vaginal atrophy
Known as:
vagina atrophy
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Atrophic vulvovaginitis
Postmenopausal atrophic vaginitis
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy
M. J. Minkin
,
R. Maamari
,
S. Reiter
International Journal of Women's Health
2013
Corpus ID: 2546914
Up to half of all postmenopausal women will experience changes in the genitourinary tract induced by the hypoestrogenic state…
Expand
Review
2012
Review
2012
An overview of chronic vaginal atrophy and options for symptom management.
N. Woods
Nursing for Women s Health
2012
Corpus ID: 26443199
During the menopausal transition and after menopause, up to 45 percent of women will develop vaginal atrophy as a consequence of…
Expand
2011
2011
Vaginal Stromal Sclerosis: A Distinctive Stromal Change Associated With Vaginal Atrophy
O. Fadare
International Journal of Gynecological Pathology
2011
Corpus ID: 9647371
The author describes 3 cases of an unusual vaginal lesion, designated as “vaginal stromal sclerosis,” that is believed to…
Expand
2008
2008
Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy…
J. Simon
,
K. Reape
,
Steven J Wininger
,
H. Hait
Fertility and Sterility
2008
Corpus ID: 11277896
Review
2003
Review
2003
Local oestrogen for vaginal atrophy in postmenopausal women.
J. Suckling
,
A. Lethaby
,
R. Kennedy
Cochrane Database of Systematic Reviews
2003
Corpus ID: 29259834
BACKGROUND Vaginal atrophy is a frequent complaint of postmenopausal women; symptoms include vaginal dryness, itching, discomfort…
Expand
2003
2003
Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women
J. Pinkerton
,
J. Shifren
,
J. La Valleur
,
A. Rosen
,
Mary Roesinger
,
S. Siddhanti
Menopause
2003
Corpus ID: 24591758
Objective To determine the potential interaction of oral raloxifene 60 mg/day on the efficacy of a low-dose, estradiol-releasing…
Expand
Review
2002
Review
2002
Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
C. Crandall
Journal of Women's Health
2002
Corpus ID: 24379564
BACKGROUND A theoretical advantage of local (i.e., vaginal) therapy of genitourinary symptoms could be avoidance of systemic…
Expand
Highly Cited
2000
Highly Cited
2000
Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy
R. Dugal
,
K. Hesla
,
Terje Sørdal
,
KATHE HELEN Aase
,
Oddvar Lilleeidet
,
Egil Wickstrøm
Acta Obstetricia et Gynecologica Scandinavica
2000
Corpus ID: 25478092
Background. Atrophic vaginitis is a common condition. This study compared the usefulness of estradiol vaginal tablets (EVT) and…
Expand
1995
1995
Low-dose 17 beta-oestradiol during maintenance therapy--a pharmacokinetic and pharmacodynamic study.
K. Nilsson
,
G. Heimer
Maturitas
1995
Corpus ID: 11428132
1987
1987
Use of Org OD 14 for the treatment of climacteric complaints.
D. De aloysio
,
A. Fabiani
,
M. Mauloni
,
F. Bottiglioni
Maturitas
1987
Corpus ID: 6776596
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE